Form 4 for PFE Pfizer
Accepted 2021-11-15 00:00:00 ET · period of report 2021-11-12 · accession 0001225208-21-013881 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-15 | 2021-11-12 | PFE | Hwang Angela | Group Pres | S - Sale | $49.60 | -26.2K | 11.3K | -70% | -$1.30M |
| D | 2021-11-15 | 2021-11-12 | PFE | Hwang Angela | Group Pres | I - Discretionary | $49.73 | +18.1K | 33.6K | +117% | +$900.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-12 | S | D | 3,412 | $49.62 | 21,959 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-12 | S | D | 800 | $49.61 | 25,371 | D | — | — | |
| 3 | Common | Common Stock | 2021-11-12 | S | D | 11,312 | $49.60 | 1 | D | — | — | |
| 4 | Common | Common Stock | 2021-11-12 | S | D | 10,646 | $49.59 | 11,313 | D | — | — | |
| 5 | Derivative | Phantom Stock Units SSP | 2021-11-12 | I | A | 18,098 | $49.73 | 33,576 | D | — · — to — | 18,098 Common Stock | (F3) This transaction constitutes an intra-plan transfer into the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan. (F2) Each unit represents one phantom share of common stock. (F4) These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. |